(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
(CIDRAP News) – The United States, Canada, and Mexico yesterday vowed to help each other during public health emergencies and outlined the types of aid they could provide and accept from each other in the event of a pandemic or other infectious disease outbreak.
(CIDRAP News) – The US Department of Health and Human Services (HHS) yesterday announced it was providing states, US territories, and four metropolitan areas with $896.7 million in public health preparedness funding, with $175 million of the total earmarked for pandemic planning.
Preparedness grantsThe bulk of the money is allocated toward Public Health Emergency Cooperative Agreements, which public health departments use to build capacity.
(CIDRAP News) – In an effort to expand the pool of antiviral drugs for influenza, the US government yesterday awarded a $102.6 million contract to BioCryst Pharmaceuticals Inc. of Birmingham, Ala., to develop peramivir, a new neuraminidase inhibitor.
(CIDRAP News) The federal government announced today that two swans in Michigan tested positive for both the H5 and N1 avian influenza subtypes, but initial genetic sequencing suggests that it is a low-pathogenic type rather than the highly pathogenic H5N1 strain spreading through birds in Asia, Europe, and Africa and causing deaths in humans.